| Analysis | Metabolite Name | Measured Value | Units | Tissue type |
|---|---|---|---|---|
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 6131.716816 | Peak area | Subcutaenous Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 9327.309138 | Peak area | Subcutaenous Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 9431.357739 | Peak area | Subcutaenous Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 9732.000694 | Peak area | Visceral Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 9734.694869 | Peak area | Visceral Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 10610.08373 | Peak area | Visceral Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 11428.78575 | Peak area | Subcutaenous Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 11662.89792 | Peak area | Subcutaenous Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 12313.69751 | Peak area | Visceral Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 12706.93688 | Peak area | Subcutaenous Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 13066.45616 | Peak area | Visceral Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 13165.9052 | Peak area | Subcutaenous Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 13833.54856 | Peak area | Visceral Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 13922.27606 | Peak area | Subcutaenous Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 14091.55758 | Peak area | Subcutaenous Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 14184.66901 | Peak area | Subcutaenous Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 14511.47671 | Peak area | Visceral Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 14557.75693 | Peak area | Visceral Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 14874.41792 | Peak area | Subcutaenous Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 15121.5436 | Peak area | Visceral Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 15122.98073 | Peak area | Subcutaenous Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 15162.59045 | Peak area | Visceral Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 15262.83105 | Peak area | Adipose Tissue_QC |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 15959.02545 | Peak area | Visceral Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 16079.51493 | Peak area | Visceral Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 16308.58109 | Peak area | Subcutaenous Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 16358.21653 | Peak area | Visceral Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 16458.61956 | Peak area | Subcutaenous Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 16545.01379 | Peak area | Subcutaenous Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 16802.32938 | Peak area | Visceral Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 16874.5587 | Peak area | Subcutaenous Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 17675.33584 | Peak area | Visceral Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 17684.39453 | Peak area | Visceral Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 17728.84435 | Peak area | Visceral Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 17868.7681 | Peak area | Visceral Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 17874.8103 | Peak area | Visceral Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 17888.6174 | Peak area | Subcutaenous Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 17957.11953 | Peak area | Visceral Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 17992.28474 | Peak area | Visceral Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 18061.41111 | Peak area | Visceral Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 18259.60547 | Peak area | Adipose Tissue_QC |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 18407.22852 | Peak area | Adipose Tissue_QC |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 18528.7027 | Peak area | Subcutaenous Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 18589.05488 | Peak area | Subcutaenous Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 18618.78125 | Peak area | Adipose Tissue_QC |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 19388.80553 | Peak area | Subcutaenous Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 19417.8576 | Peak area | Subcutaenous Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 19510.65625 | Peak area | Adipose Tissue_QC |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 19556.11235 | Peak area | Visceral Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 19683.22826 | Peak area | Subcutaenous Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 20007.98536 | Peak area | Visceral Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 20027.24422 | Peak area | Subcutaenous Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 20181.53711 | Peak area | Adipose Tissue_QC |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 20598.2785 | Peak area | Visceral Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 20631.57075 | Peak area | Visceral Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 21054.83026 | Peak area | Visceral Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 21089.84058 | Peak area | Subcutaenous Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 21215.7938 | Peak area | Subcutaenous Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 21386.6523 | Peak area | Visceral Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 21434.8572 | Peak area | Visceral Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 21838.13477 | Peak area | Visceral Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 21846.59977 | Peak area | Visceral Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 21865.76721 | Peak area | Visceral Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 22244.16706 | Peak area | Visceral Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 22252.10624 | Peak area | Visceral Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 22273.58787 | Peak area | Subcutaenous Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 22513.16642 | Peak area | Visceral Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 22984.70442 | Peak area | Visceral Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 23083.89096 | Peak area | Subcutaenous Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 23283.30936 | Peak area | Subcutaenous Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 23483.69413 | Peak area | Visceral Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 23653.85759 | Peak area | Subcutaenous Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 23695.08848 | Peak area | Subcutaenous Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 23930.24812 | Peak area | Visceral Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 24008.33499 | Peak area | Visceral Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 24052.44994 | Peak area | Visceral Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 24380.61 | Peak area | Subcutaenous Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 24840.2441 | Peak area | Visceral Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 24896.25447 | Peak area | Visceral Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 25105.75295 | Peak area | Subcutaenous Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 25199.6861 | Peak area | Subcutaenous Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 25331.57453 | Peak area | Visceral Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 25332.05642 | Peak area | Subcutaenous Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 25848.13382 | Peak area | Subcutaenous Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 26404.54368 | Peak area | Visceral Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 26861.41435 | Peak area | Subcutaenous Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 27019.58375 | Peak area | Visceral Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 27324.64835 | Peak area | Subcutaenous Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 27349.92286 | Peak area | Visceral Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 27765.27006 | Peak area | Subcutaenous Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 27870.63515 | Peak area | Visceral Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 28523.55218 | Peak area | Visceral Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 28650.21079 | Peak area | Subcutaenous Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 29530.63244 | Peak area | Subcutaenous Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 29849.94913 | Peak area | Visceral Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 30173.01397 | Peak area | Subcutaenous Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 30284.53015 | Peak area | Visceral Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 30611.22301 | Peak area | Subcutaenous Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 30670.6101 | Peak area | Visceral Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 30794.37797 | Peak area | Visceral Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 31173.30404 | Peak area | Subcutaenous Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 31190.86486 | Peak area | Subcutaenous Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 31439.84375 | Peak area | Visceral Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 31932.69482 | Peak area | Subcutaenous Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 32432.79693 | Peak area | Subcutaenous Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 33022.29683 | Peak area | Subcutaenous Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 33793.55977 | Peak area | Subcutaenous Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 34515.88332 | Peak area | Subcutaenous Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 35866.75323 | Peak area | Visceral Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 36144.11506 | Peak area | Subcutaenous Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 37548.63648 | Peak area | Visceral Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 37667.96003 | Peak area | Subcutaenous Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 38276.97194 | Peak area | Subcutaenous Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 40155.56777 | Peak area | Visceral Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 41484.32917 | Peak area | Subcutaenous Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 41963.23315 | Peak area | Subcutaenous Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 45927.53977 | Peak area | Subcutaenous Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 47546.01644 | Peak area | Visceral Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 48485.35319 | Peak area | Subcutaenous Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 51546.96602 | Peak area | Subcutaenous Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 52583.80175 | Peak area | Subcutaenous Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 52746.02593 | Peak area | Subcutaenous Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 52994.77594 | Peak area | Visceral Adipose |
| ESI/QTOF positive ion mode | 1-hexadecyl-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phosphocholine | 58201.75857 | Peak area | Visceral Adipose |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|